Team Publications :: Nationwide Children's Hospital

Publications

Center for Cardiovascular and Pulmonary Research

2012

  • Nelin TD; Joseph AM; Gorr MW; Wold LE. 2012. Direct and indirect effects of particulate matter on the cardiovascular system.  Toxicology Letters. Vol. 208, no. 3. (February 5): 293.
  • Marco Ricci, MD, Yanji Xu, PhD, Harriet L. Hammond, MS, David A. Willoughby, PhD, Lubov Nathanson, PhD, Maria M. Rodriguez, MD, Matteo Vatta, PhD, Steven E. Lipshultz, MD and Joy Lincoln, PhD. Alternative RNA splicing and gene expression profiles in early stage Hypoplastic Left Heart Syndrome. PLoS ONE, 7(1):e29784 Epub 2012

2011

  • Velten M; Hutchinson KR; Gorr MW; Wold LE; Lucchesi PA; Rogers LK. 2011. Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice.  PLoS ONE. Vol. 9, no. 6. (September): e24544. (IF: 4.411)
  • Zuo L; Youtz DJ; Wold LE. 2011. Particulate matter exposure exacerbates high glucose-induced cardiomyocyte dysfunction through ROS generation.  PLoS ONE. Vol. 8, no. 6. (August): e23116. (IF: 4.411)
  • Murray DB; Gardner JD; Wold LE. 2011. Call for papers: special issue on cardiac dysfunction in diabetes.  Life Sciences. Vol. 11-12, no. 89. (August): 415. (IF: 2.451)
  • Hua Y; Zhang Y; Ceylan-Isik AF; Wold LE; Nunn JM; Ren J. 2011. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy.  Basic Research in Cardiology. no. In press. (August) (IF: 6.128) (Formally Accepted)
  • Jeyaraj SC, Unger NT, Chotani MA. 2011. Rap1 GTPases: an emerging role in the cardiovasculature.  Life Sciences (Molecular, Cellular and Functional Basis of Therapy). Vol. 88, no. 15-16. (April 11): 645-652. (IF: 2.672)
  • Xu H; Crawford D; Hutchinson KR; Youtz DJ; Lucchesi PA; Velten M; McCarthy DO; Wold LE. 2011. Myocardial dysfunction in an animal model of cancer cachexia.  Life Sciences. Vol. 88, no. 9-10. (February 28): 406-410. (IF: 2.451)
  • Mishra R; Vijayan K; Colletti EJ; Harrington DA; Matthiesen TS; Simpson D; Goh SK; Walker BL; Almeida-Porada G; Wang D; Backer CL; Dudley SC Jr; Wold LE; Kaushal S. 2011. Characterization and functionality of cardiac progenitor cells in congenital heart patients.  Circulation. Vol. 123, no. 4. (February 1): 364-373. (IF: 14.432)
  • Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo C, Garner HR, Merrill WH, Hinton RB, Garg, V. 2011. Inhibitory role of Notch1 in calcific aortic valve disease is mediated by Sox9.  PLoS One. Vol. 6, no. 11. : e27743.
  • Roach JC, Glusman G, Hubley R, Montsaroff SZ, Holloway AK, Mauldin DE, Srivastava D, Garg V, Pollard KS, Galas DJ, Hood L, Smit AF. 2011. Chromosomal haplotypes by genetic phasing of human families.  Am J Hum Genet. Vol. 89, no. 3. : 382-397.
  • Peacock, J.D., Huk, D.J. Ediriweera, H. and Lincoln, J. Sox9 transcriptionally represses Spp1 to prevent matrix mineralization in maturing heart valves and chondrocytes. PLoS ONE, 6(10):e26769 Epub 2011
  • Tao, G., Levay, AK., Gridley, T., Lincoln, J. Snai1 is required for mmp15 expression to promote endothelial to mesenchymal transformation during endocardial cushion development. Developmental Biology 359(2):209-21, 2011
  • McBride KL and Garg V. 2011. Heredity of Bicuspid Aortic Valve: Is Family Screening Indicated?.  Heart. Vol. 97, no. 15. : 1193-1195.
  • Gorr MW, Velten C, Wold LE. 2011. Diesel particulate matter exposure exacerbates ROS formation and contractile dysfunction in diabetic cardiomyocytes [Abstract]. 2011 Experimental Biology. Washington, DC [Peer Reviewed] (Published)
  • Faul C*, Amaral AP*, Oskouei B*, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St. John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-o M, Kusek JW, Keane MG, Wolf M. Fibroblast Growth Factor 23 Induces Left Ventricular Hypertrophy. Journal of Clinical Investigation, 121(11):4393-408, 2011
  • Chotani MA; Flavahan NA. 2011. Intracellular alpha2C-adrenoceptors: storage depot, stunted development or signaling domain?.  Biochimica et Biophysica Acta-Molecular Cell Research. Vol. doi: 10.1016/j.bbamcr.2011.05.006. (IF: 5.275) (Formally Accepted)
  • Pajaniappan, M., Glober, N.K., Kennard, S., Liu, H., Zhao, N. and Lilly, B. (2011) Endothelial cells downregulate apolipoprotein D expression in mural cells through paracrine secretion and Notch signaling. Am J Physiol Heart Circ Physiol, 301, H784- 793.
  • Lincoln, J. and Yutzey, K.E. Molecular and developmental mechanisms of congenital heart valve disease. Invited review: Birth Defects Research Part A Clin Mol Teratol. 91(6):526-34, 2011
  • Ricci M, Panos AL, Lincoln J, Salerno TA, Warshauer L. Is aviation a good model to study human errors in health care? American Journal of Surgery, 2011 Sep 2
  • Marco Ricci, MD and Joy Lincoln, PhD. Molecular markers of cardiomyopathy in cyanotic pediatric congenital heart disease. Progress in Pediatric Cardiology 32(1):19-19-23, 2011
  • Ge Tao, James D. Kotick and Joy Lincoln.Heart Valve Development, Maintenance and Disease: The Role of Endothelial Cells. Current Topics In Developmental Biology, 2011. Invited Review. Accepted

2010

  • McBride KL; Garg V. 2010. Impact of Mendelian inheritance in cardiovascular disease.  Annals Of The New York Academy Of Sciences. Vol. 1214. (December 1): 122.
  • Jeyaraj SC, Unger NT, El-Dahdah NP, Sessler RJ, Zirwas M, Pleister A, Green-Church KB, McConnell B, Chotani MA. 2010. Delocalization of endogenous human microvascular smooth muscle A-kinase antagonizes the positive effects of Rap-Rho signaling on cell integrity and survival. [Abstract]. Circulation. Vol. 122, no. 21 Supplement: American Heart Association. (November 13) (IF: 14.049) [Peer Reviewed] (Published)
  • Yu S; Poe B; Schwarz M; Elliot SA; Albertine KH; Fenton S; Garg V; Moon AM. 2010. Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development.  Developmental Biology. Vol. 347, no. 1. (November 1): 92.
  • Bevan AK; Hutchinson KR; Foust KD; Braun L; McGovern VL; Schmelzer L; Ward JG; Petruska JC; Lucchesi PA; Burghes AH; Kaspar BK. 2010. Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery.  Human Molecular Genetics. Vol. 19, no. 20. (October 15): 3895.
  • Monreal G; Youtz DJ; Phillips AB; Eyman ME; Gorr MW; Velten C; Lucchesi PA; Wold LE; Gerhardt MA. 2010. Right ventricular remodeling in restrictive ventricular septal defect.  Journal Of Molecular And Cellular Cardiology. Vol. 49, no. 4. (October 1): 699-706. (IF: 5.499)
  • Maitra M; Koenig SN; Srivastava D; Garg V. 2010. Identification of GATA6 sequence variants in patients with congenital heart defects.  Pediatric Research. Vol. 68, no. 4. (October 1): 281.
  • Liu H; Zhang W; Kennard S; Caldwell RB; Lilly B. 2010. Notch3 is critical for proper angiogenesis and mural cell investment.  Circulation Research. Vol. 107, no. 7. (October 1): 860.
  • Monreal G; Youtz DJ; Phillips AB; Eyman ME; Gorr MW; Velten C; Lucchesi PA; Wold LE; Gerhardt MA. 2010. Right ventricular remodeling in restrictive ventricular septal defect.  Journal Of Molecular And Cellular Cardiology. Vol. 49, no. 4. (October 1): 699.
  • Kaushal S; Wold LE. 2010. Invited commentary.  The Annals Of Thoracic Surgery. Vol. 90, no. 1. (July 1): 197.
  • Lord KC; Shenouda SK; McIlwain E; Charalampidis D; Lucchesi PA; Varner KJ. 2010. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction.  Cardiovascular Research. Vol. 87, no. 1 (July 1): 111.
  • Lilly B; Clark KA; Yoshigi M; Pronovost S; Wu ML; Periasamy M; Chi M; Paul RJ; Yet SF; Beckerle MC. 2010. Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse.  Arteriosclerosis, Thrombosis, And Vascular Biology. Vol. 30, no. 4. (April 1): 694.
  • Ren J, Dong F, Zhao P, Wold LE, Pei J. 2010. Interaction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling.  PLoS ONE. Vol. 5, no. 4. (April): e10085. (IF: 4.411)
  • Stewart JA Jr; Massey EP; Fix C; Zhu J; Goldsmith EC; Carver W. 2010. Temporal alterations in cardiac fibroblast function following induction of pressure overload.  Cell And Tissue Research. Vol. 340, no. 1. (April 1): 117.
  • Hutchinson KR; Stewart JA Jr; Lucchesi PA. 2010. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.  Journal Of Molecular And Cellular Cardiology. Vol. 48, no. 3. (March 1): 564.
  • Hutchinson KR; Stewart JA Jr; Lucchesi PA. 2010. Extracellular matrix remodeling during the progression of volume overload-induced heart failure.  Journal Of Molecular And Cellular Cardiology. Vol. 48, no. 3 (March 1): 564.
  • Sawin, K., Gralton, K., Harrison, T.M., Malin, S., Balchunas, M.K., Brock, L., Cavegn, B., et al. Nurse researchers in children’s hospitals. J Pediatr Nurs. 2010 Oct;25(5):408-17.  20816564
    Read abstract »
    PubMed ID: 20816564
  • Harrison, T.M.  Family-centered pediatric nursing care: State of the science.  J Pediatr Nurs. 2010 Oct;25(5):335-43. 
    Read abstract »
    PubMed ID: 20816555
  • Liu H, Zhang, W., Kennard, S., Caldwell, RB, Lilly, B. 2010. Notch3 regulates angiogenesis and mural cell investment. Circ. Res. 107:860-870
    Read abstract »
    PubMed ID: 20689064
  • Liu H, Zhang, W., Kennard, S., Caldwell, RB, Lilly, B. 2010. Notch3 regulates angiogenesis and mural cell investment. Circ Res. Aug 5. [Epub ahead of print]
    Read abstract »
    PubMed ID: 20689064
  • Katz PS, Trask AJ, Lucchesi PA. 2010. Progressive coronary Artery Remodeling in diabetic db/db mice [Abstract]. FASEB J: Experimental Biology [Peer Reviewed] (Published)
  • Richards AA; Garg V. 2010. Genetics of Congenital Heart Disease.  Current Cardiology Reviews. Vol. 6, no. 2. : 91-97.
  • Hutchinson KR, Lord KC, Guggilam A, Cismowski MJ, Lucchesi PA. 2010. Reversal of volume overload leads to restoration of LV structure and function [Abstract]. Myogenesis and Cardiac Repair: Keystone Symposium (Published)
  • Sun Q, Hong X, Wold LE. 2010. Cardiovascular effects of ambient particulate air pollution exposure.  Circulation. Vol. 121, no. 25. : 2755-2765. (IF: 14.432)
  • Kaushal S, Wold LE. 2010. Invited Commentary on: Marrow stromal cells for cell-based therapy: the role of antiinflammatory cytokines in cellular cardiomyoplasty.  Annals of Thoracic Surgery. Vol. 90. : 197-198. (IF: 3.792)
  • Trask AJ, Katz PS, Lucchesi PA. 2010. Inward coronary artery remodeling in established type II diabetic mice [Abstract]: AHA Council for High Blood Pressure Research [Peer Reviewed] (Forthcoming)
  • Peacock, JD., Levay, AK., Gillaspie, D., Tao, G., Lincoln, J. Reduced sox9 function leads to calcific heart valve phenotypes in vivo. Circulation Research 106(4):712-9, 2010
  • Jeyaraj SC, Unger NT, El-Dahdah NP, Sessler RJ, Zirwas M, Pleister A, Green-Church KB, Chotani MA. 2010. Analysis of cyclic AMP-coupled signature molecules in human micro vascular smooth muscle cells shows link to stress-associated proteins. [Abstract]. FASEB J.. Vol. 24: 870.1. (IF: 7.096) (Published)
  • Lilly, B., Clark K.A., Yoshigi, M., Pronovost, S., Wu, M.L., Periasamy, M., Chi, M., Paul, R.J., Yet, S.F., and Beckerle, M.C. 2010. Loss of the SRF co-factor, cysteine-rich protein 1, attenuates neointima formation in the mouse. Arterioscler Thromb Vasc Biol. Apr;30(4):694-701.
  • Maitra M; Koenig S; Srivastava D; Garg V. 2010. GATA6 sequence variations in human congenital heart disease.  Pediatric Research. Vol. 68. : 281-285.
  • Jeyaraj SC, Joshi MS, Huang H, Unger NT, El-Dahdah NP, Wold LE, Strauch AR, Elton TS, Quilliam LA, Bauer JA, Chotani MA. 2010. Electrophysiological abnormalities in mice with genetic ablation of Rap1a GTPase. [Abstract]. FASEB J.. Vol. 24: 867.3. (IF: 7.096) (Published)
  • Monreal G., Youtz DJ, Phillips AM, Lucchesi PA, Wold LE, Gerhardt MA. Subclinical right ventricular remodeling in restrictive ventricular septal defect.  J Mol Cell Cardiol. (In press)
  • Yu, S., Poe, B., Schwarz, M., Elliot, S., Albertine, K.H., Fenton, S., Garg, V., and Moon, A.M. 2010. Fetal and post-natal lung defects reveal a novel and required role for Fgf8 in lung development.  Developmental Biology. Vol. 347. : 92-108.
  • Ricci, M., Mohapatra, B., Urbiatondo, A., Birgusingh, R.J., Morgado, M., Rodriguez, M.M., Lincoln, J., Vatta, M. Differential changes in TGF-beta/BMP signaling pathway in the right ventricular myocardium of newborns with hypoplastic left heart syndrome. Journal of Cardiac Failure 16(8):628-34, 2010
  • Monreal G, Youtz DJ, Eyman ME, Phillips AB, Lucchesi PA, Wold LE, Gerhardt MA. 2010. Subclinical right ventricular remodeling in restrictive ventricular septal defect [Abstract]: Basic Cardiovascular Sciences Symposium [Peer Reviewed] (Forthcoming)
  • McBride, K.L. and Garg, V. 2010. Impact of Mendelian Genetics in Cardiovascular Disease.  Annals of New Yor Acad Sci. Vol. 1214. : 122-137.
  • Garg, V. Growth of the Normal Human Heart. In Handbook of Growth and Growth Monitoring in Health and Disease. Edited by Victor R. Preedy. New York: Springer. (In press)

2009

2008

  • Ransom JF; King IN; Garg V; Srivastava D. 2008. A rare human sequence variant reveals myocardin autoinhibition.  The Journal Of Biological Chemistry. Vol. 283, no. 51 (December 19): 35845.
  • Stewart JA Jr; Lazartigues E; Lucchesi PA. 2008. The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?.  Circulation Research. Vol. 103, no. 11. (November 21): 1197.
  • Stewart JA Jr; Lazartigues E; Lucchesi PA. 2008. The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?.  Circulation Research. Vol. 103, no. 11 (November 21): 1197.
  • Richards AA; Santos LJ; Nichols HA; Crider BP; Elder FF; Hauser NS; Zinn AR; Garg V. 2008. Cryptic chromosomal abnormalities identified in children with congenital heart disease.  Pediatric Research. Vol. 64, no. 4 (October 1): 358.
  • Shenouda SK; Lord KC; McIlwain E; Lucchesi PA; Varner KJ. 2008. Ecstasy produces left ventricular dysfunction and oxidative stress in rats.  Cardiovascular Research. Vol. 79, no. 4 (September 1): 662.
  • Su J; Lucchesi PA; Gonzalez-Villalobos RA; Palen DI; Rezk BM; Suzuki Y; Boulares HA; Matrougui K. 2008. Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice.  Arteriosclerosis, Thrombosis, And Vascular Biology. Vol. 28, no. 8 (August 1): 1432.
  • Eid AH; Chotani MA; Mitra S; Miller TJ; Flavahan NA. 2008. Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle alpha2C-adrenoceptors.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 295, no. 1. (July 1): H266.
  • Snider P; Fix JL; Rogers R; Peabody-Dowling G; Ingram D; Lilly B; Conway SJ. 2008. Generation and characterization of Csrp1 enhancer-driven tissue-restricted Cre-recombinase mice.  Genesis (New York, N.Y.: 2000). Vol. 46, no. 3. (March 1): 167.
  • Kennard S; Liu H; Lilly B. 2008. Transforming growth factor-beta (TGF- 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression.  The Journal Of Biological Chemistry. Vol. 283, no. 3. (January 18): 1324.
  • Wold LE, Ren J. 2008. Mechanical measurement of contractile function of theisolated ventricular myocyte. In Methods in Molecular Medicine. Edited by Sreejayan N. and Ren J. Totawa, NJ: Humana Press. 263-270.
  • Hutchison, KS; Stewart, JA Jr; Lord, KC; Varner, KJ; Lucchesi, PA. 2008. Chronic volume overload alters cardiac fibroblast secretion collagen and matrix regulatory protein [Abstract]. EB2008 San Diego (Published)
  • Tian, L., Kammermeier, P.J. and Cismowski, M.J. 2008. Identification and Characterization of CIP98 as a Novel Regulator of mGluR6 (Awarded best poster in competition) [Abstract]. Kent Research Conference. Kent, OH (Published)
  • Stewart, JA Jr; Hutchinson, KJ; Lord, KC; Varner, KJ; Lucchesi, PA. 2008. Role of fibroblasts in diabetic cardiomyopathy [Abstract]. EB2008 San Diego (Published)
  • Levay, A.K., Peacock, J.D., Lu, Y., Hinton, Jr., Koch, M., Hinton, R.B., Kadler, K.E., Lincoln, J. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circulation Research 103(9): 948-56, 2008
  • Snider, P., Fix, J.L., Rogers, R., Ingram, D., Lilly, B. and Conway, S.J. 2008. Characterization of CRP1Cre mice using both ROSA26R reporter and ROSAEGFP-DT transgenic mice. Genesis, Mar 7;46(3):167-176.
  • Tian, L., Kammermeier, P.J. and Cismowski, M.J. 2008. Identification and Characterization of CIP98 as a Novel Regulator of mGluR6 [Abstract]. Experimental Biology. San Diego, CA (Published)
  • Katz, PS; Souza, FM; Reed, RE; Lord, KC; Lucchesi, PA. 2008. A role for antiotensin and oxidative stress in diabetes-induced coronary artery remodeling [Abstract]. EB2008 San Diego (Published)
  • Stewart JA Jr, Lazartigues E, Lucchesi PA. 2008. The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication?. Circ Res.. Vol. 103, no. 11: 1197-1199. (IF: 9.721)
  • Ceylan-Isik AF, Fliethman RM, Wold LE, Ren J. 2008. Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus.  Curr Diabetes Reviews. Vol. 4. : 320-328. (IF: 2.21)
  • Liu, H., Chen, B., and Lilly, B. 2008. Fibroblasts enhance blood vessel formation partially through secreted factor TIMP-1. Angiogenesis, 11; 223-234.
  • Dhanasekaran M, Karuppagounder SS, Uthayathas S, Wold LE, Parameshwaran K, Babu RJ, Suppiramaniam V, Brown-Borg HM. 2008. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.  Life Sciences. Vol. 83. : 92-95. (IF: 2.451)
  • Peacock, J.D., Lu, Y., Koch, M., Kadler, K.E., and Lincoln, J. Temporal and Spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Developmental Dynamics (237)10;3051-8, 2008
  • Kennard, S., Liu, H., and Lilly, B. 2008. TGF-ß1 downregulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem. Jan 18;283(3):1324-33.
  • Ren J, Wold LE. 2008. Mechanisms of alcoholic heart disease.  Therapeutic Advances in Cardiovascular Disease. Vol. 2, no. 6. : 497-506. (IF: 3.5)
  • Souza, FM; Katz, PS; Lord, KC; Potter, B; Vassallo, D; Lucchesi, PA. 2008. Hypertrophic remodeling of diabetic mesenteric resistance arteries is attenuated by Tempol and apocynin [Abstract]. EB2008 San Diego (Published)
  • Monreal G, Nicholson LM, Han B, Joshi MS, Phillips AB, Wold LE, Bauer JA, Gerhardt MA. 2008. Cytoskeletal remodelling of desmin is a more accurate measure of cardiac dysfunction than fibrosis or myocyte hypertrophy.  Life Sciences. Vol. 83. : 786-794. (IF: 2.451)
  • Giannone PJ, Luce WA, Nankervis CA, Hoffman TM, Wold LE. 2008. Necrotizing enterocolitis in neonates with congenital heart disease.  Life Sciences. Vol. 82. : 341-347. (IF: 2.451)
  • Liu H; Chen B; Lilly B. 2008. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1.  Angiogenesis. Vol. 11, no. 3. (January 1): 223.
  • Wold LE, Dai W, Dow JS, Kloner RA. 2008. Stem cell therapy in the heart and vasculature. In Methods in Molecular Medicine. Edited by Sreejayan N, Ren J. Totowa, NJ: Humana Press.
  • Rezk, BM; Lord, KC; Reed, RE; Hutchinson, KJ; Espinoza, C; McIlwain, E; El-Kak, AA; Varner, KJ; Lucchesi, PA. 2008. Beneficial effects of folic acid supplementation on the left ventricular volume overload [Abstract]. EB2008 San Diego (Published)
  • Eid AH?, Chotani MA?, Mitra S, Miller TJ, Flavahan NA. 2008. Cyclic AMP acts through Rap1 and JNK signaling to increase expression of cutaneous smooth muscle ?2C-adrenoceptors.  Am J Physiol. Heart Circ Physiol. Vol. 295. : H266-H272.

2007

  • Moustafa-Bayoumi M; Alhaj MA; El-Sayed O; Wisel S; Chotani MA; Abouelnaga ZA; Hassona MD; Rigatto K; Morris M; Nuovo G; Zweier JL; Goldschmidt-Clermont P; Hassanain H. 2007. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1.  The Journal Of Biological Chemistry. Vol. 282, no. 52 (December 28): 37632.
  • Rajagopal SK; Ma Q; Obler D; Shen J; Manichaikul A; Tomita-Mitchell A; Boardman K; Briggs C; Garg V; Srivastava D; Goldmuntz E; Broman KW; Benson DW; Smoot LB; Pu WT. 2007. Spectrum of heart disease associated with murine and human GATA4 mutation.  Journal Of Molecular And Cellular Cardiology. Vol. 43, no. 6 (December 1): 677.
  • Tomita-Mitchell A; Maslen CL; Morris CD; Garg V; Goldmuntz E. 2007. GATA4 sequence variants in patients with congenital heart disease.  Journal Of Medical Genetics. Vol. 44, no. 12 (December 1): 779.
  • Eid AH; Maiti K; Mitra S; Chotani MA; Flavahan S; Bailey SR; Thompson-Torgerson CS; Flavahan NA. 2007. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 293, no. 3 (September 1): H1955.
  • Zhang X; Stewart JA Jr; Kane ID; Massey EP; Cashatt DO; Carver WE. 2007. Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.  In Vitro Cellular & Developmental Biology. Animal. Vol. 43, no. 8-9. (September 1): 297.
  • Lindsley A; Snider P; Zhou H; Rogers R; Wang J; Olaopa M; Kruzynska-Frejtag A; Koushik SV; Lilly B; Burch JB; Firulli AB; Conway SJ. 2007. Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer.  Developmental Biology. Vol. 307, no. 2. (July 15): 340.
  • Guggilam A; Haque M; Kerut EK; McIlwain E; Lucchesi P; Seghal I; Francis J. 2007. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 293, no. 1 (July 1): H599.
  • Schluterman MK; Krysiak AE; Kathiriya IS; Abate N; Chandalia M; Srivastava D; Garg V. 2007. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease.  American Journal Of Medical Genetics. Part A. Vol. 143A, no. 8 (April 15): 817.
  • Chotani, MA; Eid, AH; Mitra, S; Flavahan, NA. 2007. An arginine-rich region mediates transGolgi retention of alpha2C-adrenoceptors. [Abstract]. FASEB J. Vol. 21, no. 6. (April): A1210. (IF: 7.096) (Published)
  • Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ. 2007. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.  Journal Of The American College Of Cardiology. Vol. 49, no. 7 (February 20): 811.
  • Harrison, T.M., Stewart, S., Ball, K., & Bratt, M.M. (2007). Clinical focus program: Enhancing the transition of senior nursing students to independent practice. Journal of Nursing Administration, 37(6), 311-317. 
    Read abstract »
    PubMed ID: 17563525
  • Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS,Schmittgen TD, Elton TS. 2007. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.  Journal of Biological Chemistry. Vol. 282, no. 33. : 24262-24269. (IF: 5.44)
  • Lincoln, J., Kist, R., Scherer, G. Yutzey, K.E. Sox9 is required for valve precursor cell expansion and extracellular matrix organization during mouseheart valve development. Developmental Biology 305(1):120-32, 2007
  • Tian, L., Kammermeier, P.J. and Cismowski, M.J. 2007. Identification of Proteins Interacting with mGluR6 [Abstract]. Experimental Biology. Washington, DC (Published)
  • Hutchinson, KJ; Majumdar, D; Reed, RE; Varner, KJ; Dell'Italia, LJ; Lucchesi, PA. 2007. Chronic volume overload induces an anti-fibrotic cardiac fibroblast phenotype in rat hearts [Abstract]. EB2007 (Published)
  • Bayoumi MM, Alkheraije KA, El-Sayed O, Wisel S, Sarker K, Chotani MA, Zweier JL, Nuovo G, Goldschmidt-Clermont PJ, Hassanain H. 2007. Vascular hypertrophy caused by transgenic overexpression of profilin 1.  J. Biol. Chem.. Vol. 282. : 37632-37639.
  • Saari JT, Wold LE, Duan J, Ren J, Carlson HL, Bode AM, Lentsch AB, Zeng H, Schuschke DA. 2007. Cardiac nitric oxide synthases are elevated in dietary copper deficiency.  Journal of Nutritional Biochemistry. Vol. 18, no. 7. : 443-448. (IF: 4.538)
  • Lanier, S.M., Struckhoff, A. and Cismowski, M.J. 2007. Activator of G Protein Signaling 1. San Diego, CA: UCSD-Nature Molecule Pages (doi:10.1038/mp.a000226.01). http://www.signaling-gateway.org/molecule/query?afcsid=A000226.
  • Linsley, A., Snider, P., Zhou, H., Olaopa, M., Koushik, S.V., Lilly, B., Burch, J.B., Firulli, A.B., Conway, S.J. 2007. A YY1-containing upstream 37bp enhancer is critical for expression of the periostin adhesion factor in Schwann and outflow tract endocardial cushion cell lineages. Dev. Biol. Jul 15;307(2):340-55.
  • Eid A H, Maiti K, Mitra S, Chotani MA, Flavahan S, Bailey SR, Thompson-Torgerson CS, Flavahan NA. 2007. Estrogen increases smooth muscle expression of ?2C-adrenoceptors and cold-induced constriction of cutaneous arteries.  Am J Physiol. Heart Circ Physiol.. Vol. 293. : H1955-H1961.
  • Katz, PS; Petra-Rocic, P; Souza, FM; Matrougui, K; Lord, KC; Lucchesi, PA. 2007. Increased oxidative stress modulates coronary artery remodeling and passive stiffness in db/db diabetic mice [Abstract]. EB2007 (Published)
  • Chotani, MA; Mitra, S; Eid, AH; Flavahan, NA. 2007. Rap1 and filamin-2 regulate subtype-specific, cell-surface delivery of alpha2-adrenoceptors [Abstract]. FASEB J. Vol. 21, no. 6: A1209. (IF: 7.096) (Published)

2006

  • Su J; Palen DI; Lucchesi PA; Matrougui K. 2006. Mice lacking the gene encoding for MMP-9 and resistance artery reactivity.  Biochemical And Biophysical Research Communications. Vol. 349, no. 4 (November 3): 1177.
  • McNicholas-Bevensee CM; DeAndrade KB; Bradley WE; Dell'Italia LJ; Lucchesi PA; Bevensee MO. 2006. Activation of gadolinium-sensitive ion channels in cardiomyocytes in early adaptive stages of volume overload-induced heart failure.  Cardiovascular Research. Vol. 72, no. 2 (November 1): 262.
  • Rocic P; Rezk B; Lucchesi PA. 2006. PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 291, no. 1 (July 1): H26.
  • Stewart JA Jr; Cashatt DO; Borck AC; Brown JE; Carver WE. 2006. 17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts.  Journal Of Molecular And Cellular Cardiology. Vol. 41, no. 1. (July 1): 97.
  • Cismowski MJ. 2006. Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins).  Seminars In Cell & Developmental Biology. Vol. 17, no. 3 (June 1): 334-344.

  • Garg V. 2006. Insights into the genetic basis of congenital heart disease.  Cellular And Molecular Life Sciences: CMLS. Vol. 63, no. 10 (May 1): 1141.
  • Garg V. 2006. Molecular genetics of aortic valve disease.  Current Opinion In Cardiology. Vol. 21, no. 3 (May 1): 180.
  • Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA Jr; Murray DB; Chancey AL. 2006. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.  Cardiovascular Research. Vol. 69, no. 3. (February 15): 657.
  • Sato M; Cismowski MJ; Toyota E; Smrcka AV; Lucchesi PA; Chilian WM; Lanier SM. 2006. Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma.  Proceedings Of The National Academy Of Sciences Of The United States Of America. Vol. 103, no. 3 (January 17): 797-802.

  • Sato M; Cismowski MJ; Toyota E; Smrcka AV; Lucchesi PA; Chilian WM; Lanier SM. 2006. Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma.  Proceedings Of The National Academy Of Sciences Of The United States Of America. Vol. 103, no. 3 (January 17): 797.
  • Sato, M., Cismowski, M.J., Toyota, E., Smrcka, A.V., Lucchesi, P.A., Chilian, W.M. and Lanier, S.M.  (2006) Identification of a receptor-independent activator of G-protein signaling (AGS8) in ischemic heart and its interaction with Gbg.  Proc. Natl. Acad. Sci. USA 103:797-802.
    Read abstract »
    PubMed ID: 16407149
  • Taylor CJ; Motamed K; Lilly B. 2006. Protein kinase C and downstream signaling pathways in a three-dimensional model of phorbol ester-induced angiogenesis.  Angiogenesis. Vol. 9, no. 2. (January 1): 39.
  • Cismowski, M.J. 2006. Tyrosine kinase inhibitors. xPharm. New York, NY: Elsevier, Inc.
  • Sabri A; Lucchesi PA. 2006. ANG II and cardiac myocyte contractility: p38 is not stressed out!.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 290, no. 1 (January 1): H72.
  • Wold LE, Simkhovich BZ, Kleinman MT, Nordlie MA, Dow JS, Sioutas C, Kloner RA. 2006. In vivo and in vitro models to test the hypothesis of particle-induced effects on cardiac function and arrhythmias.  Cardiovascular Toxicology. Vol. 6, no. 1. : 69-78. (IF: 1.809)
  • Taylor, C.J., Motamed, K., and Lilly, B. 2006. Protein kinase C and downstream signaling pathways in a 3-dimensional model of phorbol ester-induced angiogenesis. Angiogenesis; 9(2): 39-51.
  • Lincoln, J., Lange, A.L., Yutzey, K.E. “Hearts and Bones”: Shared regulatory mechanisms in heart valve, cartilage, tendon and bone. Review article. Developmental Biology 294; 292-302, 2006
  • Chotani, MA; Mitra, S; Flavahan, NA. 2006. Interaction with filamin2 enables translocation of alpha2C-andrenoceptors to the plasma membrane of smooth muscle cells [Abstract]. FASEB J. Vol. 20, no. 5: A1176. (IF: 7.096) (Published)
  • Nordlie MA, Wold LE, Simkhovich BZ, Sesti C, Kloner RA. 2006. Molecular aspects of ischemic heart disease: Ischemia/reperfusion-induced genetic changes and potential applications of gene and RNAi therapy.  Journal of Cardiovascular Pharmacology and Therapeutics. Vol. 11, no. 1. : 17-30. (IF: 1.969)
  • Wold LE, Ceylan-Isik AF, Fang CX, Yang X, Li SY, Sreejayan N, Privratsky JR, Ren J. 2006. Metallothionein alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of Ca(2+) cycling proteins, NADPH oxidase, Poly(ADP-Ribose) polymerase and myosin heavy chain isozyme.  Free Radical Biology and Medicine. Vol. 40, no. 8. : 1419-1429. (IF: 5.707)
  • Lincoln, J., Florer, J.B., Deutsch, G.H., Wenstrup, R.J., Yutzey, K.E. ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Developmental Dynamics 235(12);3295-3305, 2006
  • Tian, L., Cismowski, M. and Kammermeier, PJ. 2006. Identification of proteins interacting with mGluR6 [Abstract]. Neuroscience 2006. Atlanta, GA (Published)
  • Palen DI; Ouhtit A; Belmadani S; Lucchesi PA; Matrougui K. 2006. Hydrogen peroxide acts as relaxing factor in human vascular smooth muscle cells independent of map-kinase and nitric oxide.  Frontiers In Bioscience: A Journal And Virtual Library. Vol. 11 (January 1): 2526.
  • Hinton, Jr., R.B*., Lincoln, J*., Deutsch, G., Osinska, H., Benson, W., Yutzey, K.E. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circulation Research 98(11):1431-8, 2006 . *Both authors contributed equally. Front cover article.
  • Lincoln, J., Alfieri, C.M., Yutzey, K.E. BMP and FGF regulatory pathways control cartilage- and tendon-like cell lineage differentiation ofheart valve precursor cells. Developmental Biology 292;290-302, 2006
  • Chotani, MA; Mitra, S; Eid, AH; Miller, TJ; Flavahan, NA. 2006. Rap1 GTPase stimulates translocation of alpha2C-adrenoceptors from the transGolgi to the plasma membrane [Abstract]. FASEB J. Vol. 20, no. 5: A1177. (IF: 7.096) (Published)
  • Cismowski, M.J. 2006. Genistein. xPharm. New York, NY: Elsevier, Inc.
  • Struckhoff, A.P., Cismowski, M.J., Vaidyanathan, G. and Lanier, S.M. 2006. The influence of EGF, PM1 mutations and posttranslational processing on the subcellular location of AGS1/DexRas1 [Abstract]. Experimental Biology. San Francisco, CA (Published)
  • Tian, L., Cismowski, M. and Kammermeier, P.J. 2006. Identification of proteins interacting with mGluR6 [Abstract]. Biomedical Sciences Research Day. Rootstown, OH (Published)

2005

  • Corley KM; Taylor CJ; Lilly B. 2005. Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.  Journal Of Cellular Biochemistry. Vol. 96, no. 5. (December 1): 971.
  • Palen DI; Belmadani S; Lucchesi PA; Matrougui K. 2005. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.  Cardiovascular Research. Vol. 68, no. 2 (November 1): 268.
  • Rocic P; Lucchesi PA. 2005. NAD(P)H oxidases and TGF-beta-induced cardiac fibroblast differentiation: Nox-4 gets Smad.  Circulation Research. Vol. 97, no. 9 (October 28): 850.
  • Najwer I; Lilly B. 2005. Ca2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements.  American Journal Of Physiology. Cell Physiology. Vol. 289, no. 4. (October 1): C785.
  • Garg V; Muth AN; Ransom JF; Schluterman MK; Barnes R; King IN; Grossfeld PD; Srivastava D. 2005. Mutations in NOTCH1 cause aortic valve disease.  Nature. Vol. 437, no. 7056 (September 8): 270.
  • Blumer JB; Cismowski MJ; Sato M; Lanier SM. 2005. AGS proteins: receptor-independent activators of G-protein signaling.  Trends In Pharmacological Sciences. Vol. 26, no. 9 (September 1): 470-476.

  • Borg TK; Stewart JA Jr; Sutton MA. 2005. Imaging the cardiovascular system: seeing is believing.  Microscopy And Microanalysis: The Official Journal Of Microscopy Society Of America, Microbeam Analysis Society, Microscopical Society Of Canada. Vol. 11, no. 3. (June 1): 189.
  • Rothstein EC; Lucchesi PA. 2005. Redox control of the cell cycle: a radical encounter.  Antioxidants & Redox Signaling. Vol. 7, no. 5-6 (May 1): 701.
  • Hughie, HH; Rothstein, EC; Ryan, TD; Shenouda, S; Dell'Italia, LJ; Lucchesi, PA. 2005. Altered cardiac myocyte redox status is associated with the transition from compensated to decompensated heart failure in response to volume overload [Abstract]. Keystone Symposia, Steamboat Springs, CO. (April) (Published)
  • Reed, RE; Hughie, HH; Dell'Italia, LJ; Lucchesi, PA. 2005. Increased peroxynitrite production is a key mediator of LV extracellular matrix remodeling in response to acute volume overload [Abstract]. Keystone Symposia, Steamboat Springs, CO. (April) (Published)
  • Lord, KC; Reed, RE; Hicks, AR; Lucchesi, PA; Varner, KJ. 2005. Role of oxidative stress in methamphetamine-induced cardiac dysfunction [Abstract]. Keystone Symposia, Steamboat Springs, CO. (April) (Published)
  • Lucchesi PA; Belmadani S; Matrougui K. 2005. Hydrogen peroxide acts as both vasodilator and vasoconstrictor in the control of perfused mouse mesenteric resistance arteries.  Journal Of Hypertension. Vol. 23, no. 3 (March 1): 571.
  • Blumer, J.B., Cismowski, M.J., Sato, M. and Lanier, S.M. (2005) AGS proteins diversify G-protein signaling.  Trends Pharmacol. Sci. 26:470-476.
    Read abstract »
    PubMed ID: 16084602
  • Cismowski, M.J. and Lanier, S.M.  (2005) Activation of heterotrimeric G-proteins independent of a G-protein coupled receptor and the implications for signal processing.  Rev. Physiol. Biochem. Pharmacol. 155:57-80.
    Read abstract »
    PubMed ID: 16041530
  • Garg, V. and Srivastava, D. 2005. Genetic Underpinnings of Cardiogenesis and Congenital Heart Disease. In Principles of Molecular Cardiology. Edited by C. Patterson and M. Runge. New York: Springer-Verlag.
  • Wold LE, Ceylan-Isik AF, Ren J. 2005. Oxidative stress and stress signalling: menace of diabetic cardiomyopathy.  Acta Pharmacologica Sinica. Vol. 26, no. 8. : 908-917. (IF: 1.909)
  • Corley, K.M., Taylor, C.J., and Lilly, B. 2005. Hypoxia-inducible 1? modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells. J Cell Biochem., 96, 971-985.
  • Sato, M., Toyota, E., Chilian, W.M., Lucchesi, P., Cismowski, M.J. and Lanier, S.M. 2005. Identification of a hypoxia-inducible, receptor-independent activator of G-protein signaling 8 (AGS8) [Abstract]. Experimental Biology. San Diego, CA (Published)
  • Dai W, Hale SL, Martin BJ, Kuang J-Q, Dow JS, Wold LE, Kloner RA. 2005. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.  Circulation. Vol. 112, no. 2. : 214-223. (IF: 14.432)
  • Nordlie MA, Wold LE, Kloner RA. 2005. Genetic contributors toward increased risk for ischemic heart disease.  Journal of Molecular and Cellular Cardiology. Vol. 39, no. 4. : 667-679. (IF: 5.499)
  • Dai W, Wold LE, Dow JS, Kloner RA. 2005. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction.  Journal of the American College of Cardiology. Vol. 46, no. 4. : 714-719. (IF: 14.293)
  • Cao, X., Yelundur, S.A., Blumer, J.B., Cismowski, M.J., Sato, M. and Lanier, S.M. 2005. Identification of proteins interacting with AGS4 [Abstract]. Experimental Biology. San Diego, CA (Published)
  • Nawjer, I, and Lilly, B., 2005. Calcium/Calmodulin-dependent kinase IV activates Cysteine-rich Protein 1 through adjacent CRE and CArG elements. Am J Physiol Cell Physiol 289, C785-93.
  • Wold LE, Dutta K, Mason MM, Ren J, Cala SE, Schwanke ML, Davidoff AJ. 2005. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats.  Journal of Molecular and Cellular Cardiology. Vol. 39, no. 2. : 297-307. (IF: 5.499)
  • Wold LE, Aberle NA II, Ren J. 2005. Doxorubicin induces cardiomyocyte dysfunction via an oxidative stress mechanism.  Cancer Detectection and Prevention. Vol. 29, no. 3. : 294-299. (IF: 1.918)
  • Sato, M., Toyota, E., Chilian, W.M., Smrcka, A.V., Lucchesi, P.A., Cismowski, M.J. and Lanier, S.M. 2005. Identification of an ischemia-inducible receptor-independent activator of G-protein that interfaces with G Beta Gamma [Abstract]. 2nd Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences Targeting Heart Failure. Keystone, CO (Published)
  • Chotani MA; Mitra S; Eid AH; Han SA; Flavahan NA. 2005. Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 288, no. 1. (January 1): H69-H76. (IF: 3.75)
  • Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. 2005. Endothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: Role of ETB receptor, NADPH oxidase and caveolin-1.  British Journal of Pharmacology. Vol. 145, no. 3. : 323-333. (IF: 4.925)
  • Cismowski MJ; Lanier SM. 2005. Activation of heterotrimeric G-proteins independent of a G-protein coupled receptor and the implications for signal processing.  Reviews Of Physiology, Biochemistry And Pharmacology. Vol. 155 (January 1): 57-80.

  • Eid, AH; Mitra, S; Chotani, MA; Miller, TJ. 2005. A novel Rap1 signaling pathway mediates increased expression of alpha2C-adrenoceptors in human cutaneous vascular smooth muscle cells [Abstract]. Circulation. Vol. (Supplement, October 25, 2005), no. 112: II-131. (IF: 14.049) [Peer Reviewed] (Published)
  • Cismowski, M.J., Lizano, J.S., Vaidyanathan, G., Yang, Q. and Lanier, S.M. 2005. Identification of domains of AGS1 (DexRas1) required for activation of heterotrimeric G Alpha i [Abstract]. Experimental Biology. San Diego, CA (Published)

2004

2003

2002

2001

  • Lilly B; Olson EN; Beckerle MC. 2001. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells.  Developmental Biology. Vol. 240, no. 2. (December 15): 531.
  • Jeyaraj SC; Chotani MA; Mitra S; Gregg HE; Flavahan NA; Morrison KJ. 2001. Cooling evokes redistribution of alpha2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells.  Molecular Pharmacology. Vol. 60, no. 6. (December 1): 1195-1200. (IF: 4.684)
  • Wei S; Rothstein EC; Fliegel L; Dell'Italia LJ; Lucchesi PA. 2001. Differential MAP kinase activation and Na(+)/H(+) exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes.  American Journal Of Physiology. Cell Physiology. Vol. 281, no. 5 (November 1): C1542.
  • Kunte A; Ivey K; Yamagishi C; Garg V; Yamagishi H; Srivastava D. 2001. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L.  Mechanisms Of Development. Vol. 108, no. 1-2 (October 1): 81.
  • Su B; Mitra S; Gregg H; Flavahan S; Chotani MA; Clark KR; Goldschmidt-Clermont PJ; Flavahan NA. 2001. Redox regulation of vascular smooth muscle cell differentiation.  Circulation Research. Vol. 89, no. 1. (July 6): 39-46. (IF: 9.857)
  • Garg V; Yamagishi C; Hu T; Kathiriya IS; Yamagishi H; Srivastava D. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development.  Developmental Biology. Vol. 235, no. 1 (July 1): 62.
  • Rocic P; Lucchesi PA. 2001. Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin ii-induced signaling in vascular smooth muscle.  The Journal Of Biological Chemistry. Vol. 276, no. 24 (June 15): 21902.
  • Cismowski MJ; Metodiev M; Draper E; Stone DE. 2001. Biochemical analysis of yeast G(alpha) mutants that enhance adaptation to pheromone.  Biochemical And Biophysical Research Communications. Vol. 284, no. 2 (June 8): 247-254.

  • Bayer AL; Ferguson AG; Lucchesi PA; Samarel AM. 2001. Pyk2 expression and phosphorylation in neonatal and adult cardiomyocytes.  Journal Of Molecular And Cellular Cardiology. Vol. 33, no. 5 (May 1): 1017.
  • Cismowski MJ; Takesono A; Bernard ML; Duzic E; Lanier SM. 2001. Receptor-independent activators of heterotrimeric G-proteins.  Life Sciences. Vol. 68, no. 19-20 (April 6): 2301-2308.

  • Jeyaraj, SC; Chotani, MA; Mitra, S; Flavahan, S; Gregg, HE; Flavahan, NA; Morrison, KJ. 2001. Cold-induced redistribution of alpha2C-adrenergic receptors [Abstract]. FASEB J. Vol. 15, no. 4: A217. (IF: 7.096) (Published)
  • Wold LE, Saari JT, Ren J. 2001. Isolated ventricular myocytes from copper-deficient rat hearts exhibit enhanced contractile function.  American Journal of Physiology - Heart and Circulatory Physiology. Vol. 281, no. 2. : H476-H481. (IF: 3.881)
  • Lilly, B., Olson, E.N., and Beckerle, M.C. 2001. Identification of a CArG box-dependent enhancer within the CRP1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev. Biol. 240, 531-547.
  • Rocic, P; Lucchesi, PA. 2001. PYK2 antisense inhibits angiotensin II-induced protein synthesis through ERK1/2 MAP kinases and Akt in vascular smooth muscle [Abstract]. FASEB J. Vol. 15: A488. (Published)
  • Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J. 2001. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes.  Journal of Molecular and Cellular Cardiology. Vol. 33, no. 9. : 1719-1726. (IF: 5.499)
  • Ren J, Wold LE. 2001. Measurement of cardiac mechanical function in isolated ventricular myocytes from rats and mice by computerized video-based imaging.  Biological Procedures Online. Vol. 3, no. 1. : 43-53. (IF: 0.742)
  • McRae, CN; Lucchesi, PA; Berecek, KH. 2001. Differential ERK1/2 MAP kinase activation by angiotensin II in SHR and WKY cardiac fibroblasts [Abstract]. FASEB J. Vol. 15: A486. (Published)
  • Hintz KK, Wold LE, Colligan PB, Scott GI, Lee KJ, Sowers JR, Ren J. 2001. Influence of ovariectomy on ventricular myocyte contraction in simulated diabetes.  Journal of Biomedical Science. Vol. 8, no. 4. : 307-313. (IF: 1.962)
  • Lako, M., Lindsay, S., Lincoln, J., Cairns, P.M., Armstrong, L., Hole, N. Charaterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation. Mechanisms of Development 103, 49-59 2001
  • Jeyaraj, SC; Chotani, MA; Mitra, S; Flavahan, S; Flavahan, NA; Morrison, KJ. 2001. Cooling induces redistibution of alpha2C-adrenergic receptors in HEK293 cells [Abstract]. J Vas Res. Vol. 38, no. (S1): 14. (IF: 2.634) (Published)
  • Rocic P; Govindarajan G; Sabri A; Lucchesi PA. 2001. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle.  American Journal Of Physiology. Cell Physiology. Vol. 280, no. 1 (January 1): C90.
  • Wei, S; Anderson, PA; Lucchesi, PA. 2001. Altered regulation of MAP kinases by oxidative stress in adult cardiac myocytes during the development of pressure-overload hypertrophy [Abstract]. FASEB J. Vol. 15: A502. (Published)
  • Vaidyanathan, G., Cismowski, M.J., Vincent, T.S., Duzic, E. and Lanier, S.M. 2001. Tissue distribution and characterization of AGS1, a receptor independent activator of G-protein signaling [Abstract]. ASPET Colloquium on G Protein Coupled Receptors. Orlando, FL (Published)
  • Perry, GJ; Mori, T; Wei, CC; Xu, XY; Chen, YF; Oparil, S; Lucchesi, P; Dell'Italia, LJ. 2001. Genetic variation in angiotensin-converting enzyme does not prevent development of cardiac hypertrophy or upregulation of angiotensin II in response to aortocaval fistula.  Circulation. Vol. 103: 1012.
  • Wold LE, Norby FL, Hintz KK, Colligan PB, Epstein PN, Ren J. 2001. Prenatal ethanol exposure alters ventricular myocyte contractile function in the offspring of rats: Influence of maternal Mg2+ supplementation.  Cardiovascular Toxicolology. Vol. 1, no. 3. : 215-224. (IF: 1.809)
  • Sun, JZ; Oparil, S; Lucchesi, PA; Thompson, JA; Chen, YF. 2001. Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cells.  Am J Physiol Lung Cell Mol Physiol. Vol. 281: 155-163.

2000

  • Govindarajan G; Eble DM; Lucchesi PA; Samarel AM. 2000. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells.  Circulation Research. Vol. 87, no. 8 (October 13): 710.
  • Chotani MA; Touhalisky K; Chiu IM. 2000. The small GTPases Ras, Rac, and Cdc42 transcriptionally regulate expression of human fibroblast growth factor 1.  The Journal Of Biological Chemistry. Vol. 275, no. 39. (September 29): 30432-30438. (IF: 5.44)
  • Cismowski MJ; Ma C; Ribas C; Xie X; Spruyt M; Lizano JS; Lanier SM; Duzic E. 2000. Activation of heterotrimeric G-protein signaling by a ras-related protein. Implications for signal integration.  The Journal Of Biological Chemistry. Vol. 275, no. 31 (August 4): 23421-23424.

  • Chotani MA; Flavahan S; Mitra S; Daunt D; Flavahan NA. 2000. Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.  American Journal Of Physiology. Heart And Circulatory Physiology. Vol. 278, no. 4. (April 1): H1075-H1083. (IF: 3.75)
  • Morrison, KJ; Chotani, MA; Flavahan, S; Mitra, S; Gregg, HE; Duant, DA; Flavahan, NA. 2000. Alpha2C-adrenoceptors and cold-induced vasospasm [Abstract]. FASEB J. Vol. 14, no. 8: A1315, May 11, 2000, abstract 27. (IF: 7.096) (Published)
  • Armstrong, L., Lako, M., Lincoln, J., Cairns, P.M., Hole, N. mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mechanisms of Development 97, 109-116, 2000
  • Ren J, Wold LE, Epstein PN. 2000. Diabetes enhances acetaldehyde-induced depression of cardiac myocyte contraction.  Biochemical and Biophysical Research Communications. Vol. 269, no. 3. : 697-703. (IF: 2.595)
  • Stewart JA Jr; Brower GL; Janicki JS. 2000. Correlation of matrix metalloproteinase (MMP) activity and mast cell density in mitral regurgitation (MR) [Abstract]. J Mol Cell Cardiol. Vol. 32: A-69. (Published)
  • Stewart JA Jr; Wei CC; Lucchesi PA; Janicki JS; Brower GL; Dell'Italia LJ. 2000. Differential activation of ACE and chymase during early and late phases of left ventricular remodeling in response to the volume overload of mitral regurgitation [Abstract]. Circulation. Vol. 18, Suppl. 2, no. 102: 11-131. (Published)
  • Takesono, A., Cismowski, M.J., Nowak, M.W., Duzic, E. and Lanier, S.M. 2000. Regulation of GIRK channel activity and ERK1/2 by Activator of G-protein Signaling (AGS) Proteins [Abstract]. FASEB J. no. 14. Boston, MA: 996. (Published)
  • Chotani, MA; Mitra, S; Su, BY; Flavahan, S; Paris, H; Daunt, DA; Handy, DE; Clark, KR; Flavahan, NA. 2000. Regulation of alpha2C-adrenergic receptor expression in vasular smooth muscle cells [Abstract]. FASEB J. Vol. 14, no. 8: A1315. (IF: 7.096) (Published)
  • Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J. 2000. Leptin attenuates cardiac contraction in rat ventricular myocytes: Role of NO.  Hypertension. Vol. 36, no. 4. : 501-505. (IF: 6.908)
  • Cismowski, M.J. 2000. Receptor independent activators of heterotrimeric G-proteins [Abstract]. American Society for Biochemistry and Molecular Biology/American Society for Pharmacology and Experimental Therapeutics Joint Meeting. Boston, MA (Published)

1999

  • Takesono A; Cismowski MJ; Ribas C; Bernard M; Chung P; Hazard S 3rd; Duzic E; Lanier SM. 1999. Receptor-independent activators of heterotrimeric G-protein signaling pathways.  The Journal Of Biological Chemistry. Vol. 274, no. 47 (November 19): 33202-33205.

  • Cismowski MJ; Takesono A; Ma C; Lizano JS; Xie X; Fuernkranz H; Lanier SM; Duzic E. 1999. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling.  Nature Biotechnology. Vol. 17, no. 9 (September 1): 878-883.

  • Stronach BE; Renfranz PJ; Lilly B; Beckerle MC. 1999. Muscle LIM proteins are associated with muscle sarcomeres and require dMEF2 for their expression during Drosophila myogenesis.  Molecular Biology Of The Cell. Vol. 10, no. 7. (July 1): 2329.
  • Yamagishi H; Garg V; Matsuoka R; Thomas T; Srivastava D. 1999. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects.  Science (New York, N.Y.). Vol. 283, no. 5405 (February 19): 1158.
  • Lilly, B., O’keefe, D.D., Thomas, J.B., and Botas, J. 1999. The LIM homeodomain protein dLim1 defines a subclass of neurons within the embryonic ventral nerve cord of Drosophila. Mech. Dev. 88, 195-205.
  • Takesono, A., Cismowski, M., Ma, C., Xie, X., Bernard, M., Ribas, C., Fuernkranz, H., Hazard, S., Chung, P., Duzic, E. and Lanier, S.M. 1999. Stimulus input to heterotrimeric G-protein signaling pathways [Abstract]. The Gordon Research Conference on Molecular Pharmacology. Ventura, CA (Published)
  • Bernard, M., Cismowski, M., Ribas, C., Takesono, A., Duzic, E. and Lanier, S.M. 1999. Interaction of AGS (Activators of G-protein Signaling) proteins with G-protein subunits [Abstract]. The Gordon Research Conference on Molecular Pharmacology. Ventura, CA (Published)
  • Lilly B; Botas J. 1999. Genetic analysis and generation of a duplication that covers the 8B region of the X chromosome in Drosphila melangaster.  Dros Info Serv. Vol. 82. : 105-112.
  • Stronach, B.E., Renfranz, P.J., Lilly, B. and Beckerle, M.C. 1999. Muscle LIM proteins are associated with sarcomeres and require dMEF2 for their expression during Drosophila myogenesis. Mol. Biol. Cell, 10, 2329-2342.
  • Lilly, B., and Botas, J. 1999.  Genetic analysis and generation of a duplication that covers the 8B region of the X chromosome in Drosophila melanogaster.  Dros. Info. Serv. 82, 105-112.
  • Cismowski, M.J., Ma, C., Ribas, C., Xie, X., Spruyt, M., Fuernkranz, H., Lanier, S.M. and Duzic, E. 1999. A novel human ras-related protein is a receptor-independent activator of a heterotrimeric G-protein [Abstract]. Keystone Symposium. Sante Fe, NM (Published)
  • Arora-Kuruganti P; Lucchesi PA; Wurster RD. 1999. Proliferation of cultured human astrocytoma cells in response to an oxidant and antioxidant.  Journal Of Neuro-Oncology. Vol. 44, no. 3 (January 1): 213.
  • Chotani, MA; Mitra, S; Su, BY; Flavahan, S; Paris, H; Daunt, DA; Handy, DE; Flavahan, NA. 1999. Microvascular smooth-muscle specific expression of alpha2C-adrenergic receptor: role of oxidant stress and stress-activated protein kinase p38 in gene regulation [Abstract]. Circulation. Vol. (Supplement) 100, no. 18: I-848, November 2, 1999, abstract 4479. (IF: 14.049) [Peer Reviewed] (Published)
  • Chotani, MA; Flavahan, S; Mitra, S; Daunt, DA; Flavahan, NA. 1999. Silent alpha2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries: a mechanism for Raynaud's Phenomenon? [Abstract]. Circulation. Vol. (Supplement) 100, no. 18: I-554, November 2, 1999, abstract 2922. (IF: 14.049) [Peer Reviewed] (Published)
  • Lilly B; O'Keefe DD; Thomas JB; Botas J. 1999. The LIM homeodomain protein dLim 1 defines a subclass of neurons within the embryonic ventral nerve cord of Drosphila.  Mech Dev. Vol. 88. : 195-205.

1998

1997

1996

1995

1994

1993

1992

  • Cserjesi P; Lilly B; Bryson L; Wang Y; Sassoon DA; Olson EN. 1992. MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer.  Development (Cambridge, England). Vol. 115, no. 4. (August 1): 1087.
  • Cserjesi, P., Lilly, B., Bryson, L., Wang, Y., Sassoon, D.A. and Olson, E.N. 1992. MHox: a mesodermally-restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development  115, 1087-1101.
  • Cismowski, M.J. and Reed, S.I. 1992. In vitro reconstitution of Cdc28 protein kinase activity [Abstract]. The Cell Cycle: Cold Spring Harbor Laboratory Symposium (Published)

1991

1990

1989

  • Hodgson, CP; Fisk, RZ; Hatzoglu, M; Arora, P; Chotani, MA; Hanson, RW. 1989. Mouse retrovirus-like (VL-30) transposable element RNA is abundantly expressed in psi-3 helper cells, transferred to recipient rat hepatoma cells, and expressed in dexamethasone-inducible fashion along w/specifically vectored sequences: complete structure [Abstract]. J Cell Biochem. Vol. Supplement 13D, no. abstract K415 (IF: 3.285) (Published)
  • Lucchesi PA; Romano FD; Scheid CR; Yamaguchi H; Honeyman TW. 1989. Interaction of agonists and selective antagonists with gastric smooth muscle muscarinic receptors.  Naunyn-Schmiedeberg's Archives Of Pharmacology. Vol. 339, no. 1-2 (January 1): 145.

1988

1986

1985

1984

  • Cismowski, M., Au, L-C., Pine, R., Liu, S. and Huang, P.C. 1984. Construction and sequence analysis of a metallothionein cDNA mutant library [Abstract]. Federation Proceedings. no. 43: 1888. (Published)

  • Chotani, MA; Mitra, S; Su, BY; Flavahan, S; Paris, H; Daunt, DA; Handy, DE; Flavahan, NA, Presenter. 1999. Microvascular smooth-muscle specific expression of alpha2C-adrenergic receptor: role oxident stress and stress-activated protein kinase p38 in gene regulation. Presented at The American Heart Association Meeting. 72nd Scientific Sessions. Atlanta, GA. (November)
  • Backes C, Wold LE. 2011. Fetal effects of air pollution exposure. Pediatrics. [Peer Reviewed] (First submission)
  • Goldsmith EC; Stewart JA Jr; Morales MO; Wilson CG; Carver WE, Poster Presenter. 2007. Fibrin Gels as a Novel Model for Examining Collagen Organization by Cardiac Fibroblasts. Presented at Experimental Biology. Washington DC.
  • Lucchesi, P, Presenter. 2000. Reactive oxygen species and cardiac remodeling. Plenary Speaker, American Heart Association Scientific Sessions. Washington, DC.
  • Lucchesi, P, Presenter. 2002. NHE-1 in cardiac myocytes. Experimental Biology. New Orleans, LA.
  • Lucchesi, P, Presenter. 2010. Diabetes and the Heart: The Biggest Loser? Keynote Speaker, Experimental Biology. Anaheim, CA.
  • NA Flavahan; S Flavahan; MA Chotani; S Mitra; B Su, Co-Discoverer. filed June 9, 2000 and issued September 3, 2002. Methods and Compositions for Treating Raynaud's Phenomenon and Scleroderma. patent no. 6,444,681. The Ohio State University.
  • Lucchesi, P, Presenter. 2001. Regulation of Na+/H+ exchange in myoctyes. International Society for Heart Research.
  • Chotani, MA; Winkles, JA; Chiu, I-M, Poster Presenter. 1993. Identification and distribution of a novel human acidic fibroblast growth factor mRNA: a fourth variant having alternative 5' untranslated exon. Presented at Poster Session for the 19th Annual ICSABER Society Graduate Research Forum. The Ohio State University. Columbus, OH. (May)
  • Chiu, I-M; Myers, RL; Payson, RA; Chotani, MA, Presenter. 1993. Differential expression of acidic fibroblast growth factors mRNA: gene structure and distribution of four different aFGF transcripts. Presented at Poster Session for Keystone Symposia on Extracellular Matrix in Development and Disease. Breckenridge, CO. (March)
  • Lucchesi, P, Poster Presenter. 2005. Molecular mechanisms of heart failure. Keystone Symposia. Steamboat Springs, CO.
  • Cismowski, M. and Duzic, E. issued December 5, 2006. AGS proteins and nucleic acid molecules and uses therefor. patent no. 7,144,711.
  • Chotani, MA, Presenter. 1994. Some aspects of FGF-1 gene expression. Presented at Sixth Annual Ohio State University Molecular Biology Meeting. Stone Laboratory. Gibralter Island, OH. (September)
  • Lucchesi, P, Presenter. 1999. Activation of Na+/H+ exchange in cardiac myocytes. Plenary Lecture, International Society for Heart Research. Winnepeg, Manitoba, Canada.
  • Mihai, C; Chotani, MA; Elton, TS; Agarwal, G, Presenter. 2007. Does collagen type 1 modulate oligomerization of DDR1? Presented at 51st Biophysical Society Meeting. Baltimore, MD. (March)
  • Lucchesi, P, Presenter. 1988. Indentification of muscarinic cholinergic receptors in trachael smooth muscle. FASEB Meeting. Philadelphia, PA.
  • Chotani, MA, Presenter. 1994. Gene expression of human fibroblast growth factor-1 (FGF-1) is modulated by alternate promotors in response to serum, PMA. and TGF-beta1. Presented at The Scott Falkenthal Memorial Graduate Student Colloquium. Department of Molecular Genetics, The Ohio State University. Columbus, OH. (January)
  • Su, BY; Mitra, S; Gregg, H; Flavahan, S; Chotani, MA; Baldwin, WM; Goldschmidt-Clermont, PJ; Flavahan, NA, Presenter. 2000. Regulation of expression of the proapoptotic protein, BAD, by phenotypic modulation of vascular smooth muscle cells. Presented at First Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. Denver, CO. (May)
  • Chotani, MA, Presenter. 1995. Heparin and oncogenic ras modulate gene expression of fibroblast growth factor-1: towards an understanding of the biological significance of alternate promoter usage by a growth factor gene. Presented at The Scott Falkenthal Memorial Graduate Student Colloquium. The Department of Molecular Genetics, The Ohio State University. Columbus, OH. (January)
  • Chotani, MA; Mitra, S; Flavahan, NA, Presenter. 2006. Interaction with filamin2 enables translocation of alpha 2C-adrenoceptors ot the plasma membrane of smooth muscle cells. Presented at Experimental Biology 2006. San Francisco, CA. (April)
  • Chotani, MA, Seminar Presenter. 2003. Expression of alpha2-adrenoceptors in human vascular smooth muscle cells. Presented at The Aga Khan University College of Medicine, to Faculty, staff, medical students. The Department of Biological and Biomedical Sciences. Karachi, Pakistan. (August)
  • Savla, M; Sun, P; Rathman, J; Chotani, MA; Agarwal, G, Presenter. 2005. DIP pen nanolithography: a novel approach to study lipid-protein interaction. Presented at 4th Annual Ohio State University Medical Center Graduate & Postgraduate Research Day. Columbus, OH. (March)
  • Wold LE, Ying Z, Hutchinson KR, Velten M, Gorr MW, Velten C, Youtz DJ, Wang A, Lucchesi PA, Sun Q, Rajagopalan S. 2011. Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Journal of the American Medical Association. [Peer Reviewed] (First submission)
  • Mihai, C; Vikram, DS; Chotani, MA; Agarwal, G, Presenter. 2004. Does glycosylation mediate discoidin domain receptor (DDR)-collagen interaction? Presented at 3rd Annual Ohio State University Medical Center Graduate & Postgraduate Research Day. Columbus, OH. (April)
  • Cismowski, M. and Duzic, E. issued June 8, 2004. AGS proteins and nucleic acid molecules and uses thereof. patent no. 6,746,852.
  • Zuo L, Youtz DJ, MacMillan AC, Gorr MW, Wold LE. 2011. Acute diesel exhaust particle treatment causes cardiomyocyte dysfunction through enhanced reactive oxygen species production. American Journal of Physiology ? Heart and Circulatory Physiology. [Peer Reviewed] (Revised submission)
  • Lucchesi, P, Presenter. 2001. PI 3-kinase signaling in vascular smooth muscle. Experimental Biology. Washington, DC.
  • Chotani, MA, Seminar Presenter. 1995. Gene regulation of human fibroblast growth factor-1. Presented at The Clayton Foundation Laboratories for Peptide Biology, to Faculty, staff, students. The Salk Institute for Biological Studies. La Jolla, CA. (August)
  • Chotani, MA; Mitra, S; Flavahan, S; Flavahan, NA, Presenter. 2003. Distinct cyclic AMP signaling pathways differentially regulate alpha2C-adrenoceptor expression in human arteriolar vascular smooth muscle cells. Presented at American Heart Association Meeting. Scientific Sessions 2003. Orlando, FL. (November)
  • Joseph AM, McKenzie LB, Fields SK, Collins CL, Lucchesi PA, Comstock RD, Wold LE. 2011. Consumption of energy and sports drinks by high school athletes: a link to excessive BMI?. Pediatrics. [Peer Reviewed] (First submission)
  • Chotani, MA; Jeyaraj, SC; Mitra, S; Morrison, KJ; Flavahan, S; Flavahan, NA, Presenter. 2003. Induction of alpha2C-adrenoceptors in human microvascular smooth muscle cells by cyclic AMP dependent, but A-kinase independent signaling. Presented at Experimental Biology 2003. American Society for Pharmacology & Experimental Therapeutics. San Diego, CA. (April)
  • Schaffer SW, Davidoff AJ, Mozaffari M, Wold LE. 2011. Oxidative stress in the development of diabetic complications: role of hyperglycemia, hyperlipidemia and angiotensin II. Journal of Molecular and Cellular Cardiology. [Peer Reviewed] (Revised submission)
  • Su, BY; Mitra, S; Gregg, H; Flavahan, S; Chotani, MA; Goldschmidt-Clermont, PJ; Flavahan, NA, Presenter. 2000. Redox regulation of vascular smooth muscle differentiation. Presented at First Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. Denver, CO. (May)
  • Joshi, MS; Bauer, JA; Wold, LE; Strauch, AR; Elton, TS; Quilliam, LA; Chotani, MA, Poster Presenter. 2008. Cardiac abnormalities in mice with genetic ablation of Rap1A GTPase (Award winning poster). Presented at Research Retreat Abstract Competition. Davis Heart & Lung Research Institute, The Ohio State University College of Medicine. Columbus, OH. (October 21)
  • Chotani, MA; Chiu, I-M, Presenter. 1997. Cellular and molecular analysis of regulatory mechanisms of human fibroblast growth factor 1 gene expression. Presented at 23rd Annual ICSABER Society Graduate Research Forum. The Ohio State University. Columbus, OH. (May)
  • Morrison, KJ; Chotani, MA; Flavahan, S; Mitra, S; Gregg, HE; Daunt, DE; Flavahan, NA, Presenter. 2000. Alpha2C-adrenoceptors and cold-induced vasospasm. Presented at ASBMB/ASPET 2000 Meeting. Boston, MA. (May)
  • Lucchesi, P, Presenter. 2002. Mechanisms of oxident stress induced heart failure. AHA Scientific Conference on Advances in Molecular and Cellular Mechanisms of Heart Failure. Salt Lake City, UT.
  • Eid, A; Mitra, S; Chotani, MA; Flavahan, S; Flavahan, NA, Presenter. 2005. Estrogen increases alpha2C-adrenoceptor expression in human microvascular smooth muscle cells. Presented at Experimental Biology 2005. (April)
  • Chotani, MA; Chiu, I-M, Presenter. 1997. Functional analysis of human fibroblast growth factor-1 promoters shows linkage to Ras, Rac1, and Cdc42 signaling. Presented at 9th Annual Ohio State University Molecular Biology Program Stone Laboratory Meeting. Gibralter Island, OH. (September)
  • Eid, A; Mitra, S; Chotani, MA; Miller, TJ; Flavahan, NA, Presenter. 2005. A novel Rap1 signaling pathway mediates increased expression of alpha2C-adrenoceptors in human cutaneous vascular smooth muscle cells. Presented at American Heart Association Meeting. Scientific Sessions 2005. Dallas, TX. (November)
  • Chotani, MA, Seminar Presenter. 2007. Rap1 and filamin-2 regulate sub-type specific, cell surface delivery of alpha2-adrenoceptors. Presented at Experimental Biology 2007 Symposium, to Session attendees. Featured Topic Session on Receptor Biology: Intracellular Signaling and Second Messengers. Washington, DC. (April)
  • Cismowski, M. and Duzic, E. issued May 11, 2004. AGS proteins and nucleic acid molecules and uses therefor. patent no. 6,733,991.
  • Chotani, MA, Seminar Presenter. 2009. Regulated cell surface delivery of alpha2C-adrenoceptors (CME approved presentation). Presented at Research Day, to Session attendees. The Research Institute at Nationwide Children's Hospital. Columbus, OH. (May 15)
  • Lucchesi, P, Presenter. 1987. Regulation of Ca2+ -ATPase activation in gastric smooth muscle. FASEB Meeting. Washington.
  • Piletz, JE; Sarasua, MM; Chotani, MA. 1990. Higher platelet internal membrane fluidity in Alzheimer's patients versus controls. Presented at Second International Conference on Alzheimer's Disease and Related Disorders. Toronto, Canada. (July)
  • Cismowski, M.J., Poster Presenter. 2000. Receptor independent activators of heterotrimeric G-proteins. Presented at American Society for Biochemistry and Molecular Biology/American Society for Pharmacology and Experimental Therapeutics Joint Meeting. Boston, MA.
  • MA Chotani, JA Bauer, MS Joshi, SC Jeyaraj, Co-discoverer. filed April 27, 2011. (patent pending) Rap1A as a marker for cardiac arrhythmia. patent no. Provisional. The Research Institute at Nationwide Children's Hospital. Disc. Date: January 2011.
  • Chotani, MA, Presenter. 1995. Transforming growth factor-beta1 and heparin modulate gene expression of fibroblast growth factor-1: towards an understanding of the biological significance of alternate promotor usage by a growth factor gene. Presented at Graduate Research Forum. The Ohio State University. Columbus, OH. (April)
  • Myers, RL; Payson, RA; Chotani, MA; Chui, I-M, Presenter. 1992. Tissue specific expression of multiple aFGF transcripts containing different 5' untranslated exons. Presented at Poster Session for Meeting of the American Society of Biochemistry, Molecular Biology and Biophysics. Houston, TX. (February)
  • Lucchesi, P, Presenter. 1992. Developmental expressions Na+, K+, -ATPase isoforms in post natal rat hearts. Biophysical Society Meeting. Baltimore, MD.
  • Payson, RA; Chotani, MA; Myers, RL; Harris, SE; Chiu, I-M, Presenter. 1993. Alternate 5' untranslated exon/promotor usage renders tissue-specific transcriptional regulation of the human acidic fibroblast growth factor gene (aFGF). Presented at Poster Session for Keystone Symposia on Transcription: Factors, Regulation and Differentiation. Keystone, CO. (January)
  • Ostanin, K., Cismowski, M. and Silverman, L. issued May 27, 2007. Cell surface proteins and use thereof as indicators of activation of cellular signal transduction pathways. patent no. 7,223,533.
  • Lucchesi, P, Presenter. 2004. Regulation of the myocardial remodeling by matrix metalloproteinases. Experimental Biology. Washington, DC.
  • Barcelo-Coblijn G, Wold LE, Ren J, Murphy EJ. 2011. Prenatal ethanol exposure alters brain cholesterol content in adult rats. Lipids. [Peer Reviewed] (Revised submission)
  • Chotani, MA, Mitra S, Eid AH, Miller TJ, Flavahan NA, Presenter. 2006. Rap1 GTPase stimulates translocation of alpha2C-adrenoceptors from the transGolgi to the plasma membrane. Presented at Experimental Biology 2006. San Francisco, CA. (April)
  • Souza-Smith FM; Katz PS; Stewart JA Jr; Vassallo D; Lucchesi PA, Poster Presenter. 2009. Vascular Remodeling of Mesenteric Resistance Arteries in Diabetic (db/db) Mice. Presented at Experimental Biology. New Orleans, LA.
  • Stewart JA Jr; Cashatt DO; Borck AC;Brown JE; Carver WE, Poster Presenter. 2006. 17beta-Estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. Presented at Keystone Symposia. Santa Fe, NM.
  • Chotani, MA, Presenter. 1992. Characterization of a novel form of human aFGF mRNA. Presented at Fourth Annual DNA Virus/Gene Expression Meeting. Stone Laboratory, The Ohio State University. Gilbrater Island, OH. (September)
  • Huang, H; Joshi, MS; Bauer, JA; Wold, LE; Strauch, AR; Elton, TS; Quilliam, LA; Chotani, MA, Presenter. 2009. Cardiac abnormalities in mice with genetic ablation of Rap1A GTPase (Oral competition finalist). Presented at Research Day. The Research Institute at Nationwide Children's Hospital. Columbus, OH.
  • Chotani, MA; Flavahan, S; Mitra, S; Daunt, DA; Flavahan, NA, Presenter. 1999. Silent alpha2C-adrenegic receptors enable cold-induced vasoconstriction in cutaneous arteries: a mechanism of Reynaud's Phenomenon? Presented at The American Heart Association Meeting. 72nd Scientific Sessions. Atlanta, GA. (November)
  • A Audino, C Cua, L Tang, N Barry, M Cismowski, M Rhodes, Presenter. 2010. Prognostic value of pro-bnp and vegf in children with sickle cell disease. Presented at American Society of Pediatric Hematology/Oncology Meeting. Montreal, Quebec, Canada. (April)
  • Joseph A, Youtz DJ, Konopka Z, Wold LE. 2011. Health benefits of grape seed oil. Journal of Alternative and Complementary Medicine. [Peer Reviewed] (First submission)
  • Chotani, MA; Jeyaraj, S; Mitra, S; Morrison, KJ; Flavahan, S; Flavahan, NA, Presenter. 2002. Role of COX-2 and cylic AMP in regulating expression of alpha2C-adrenoceptors in human microvascular smooth muscle cells. Presented at 10th International Symposium on Vascular Neuroeffector Mechanisms. Granlibakken, Lake Tahoe, CA. (July)
  • Myers, RL; Chotani, MA; Chiu, I-M, Poster Presenter. 1994. Transcriptional regulation of human FGF-1: potential interaction between positive and negative regulatory proteins. Presented at Keystone Symposia on Molecular Biology of the Endothelial Cell. Keystone, CO. (January)
  • Lucchesi, P, Presenter. 2000. Regulation of vascular smooth muscle cells. FASEB Summer Research Conference. Snowmass, CO.
  • Chotani, MA; Winkles, JA; Chiu, I-M, Poster Presenter. 1994. Promotor switching of FGF-1 gene expression in vascular smooth muscle cells in response to serum and phorbol ester. Presented at Keystone Symposia on Inflammation, Growth Regulatory Molecules and Atherosclerosis. Keystone, CO. (January)
  • Chotani, MA; Chiu, I-M, Poster Presenter. 1994. Increased levels of FGF-1 mRNA in response to serum, phorbol ester, and TGF-beta1: identification of variant transcripts arising from alternate promotors. Presented at Poster Session for the 20th Annual ICSABER Society Graduate Research Forum. The Ohio State University. Columbus, OH. (May)
  • Eid, AH; Chotani, MA; Mitra, S; Flavahan, S; Flavahan, NA, Presenter. 2004. Estrogen increases alpha2C-adrenoceptor expression in human microvascular smooth muscle cells. Presented at 3rd Annual Ohio State University Medical Center Graduate & Postgraduate Research Day. Columbus, OH. (April)
  • Cismowski, M.J., Ma, C., Ribas, C., Xie, X., Spruyt, M., Fuernkranz, H., Lanier, S.M. and Duzic, E., Poster Presenter. 1999. A novel human ras-related protein is a receptor-independent activator of a heterotrimeric G-protein. Presented at Keystone Symposium. Santa Fe, NM.
  • Lucchesi, P, Presenter. 1997. Oxidative stress and sarcomeric organization in cardiac myocytes. American Heart Association Scientific Sessions.
  • Hutchinson KR; Lord KC; Stewart JA Jr; Guggilam A; Zhang XJ; Cismowski MJ; Lucchesi PA, Chair. 2010. Reversal of volume overload leads to restoration of LV structure and function. Presented at Keystone Symposia. Keystone, CO.
  • Chotani, MA, Seminar Presenter. 1997. Cellular and molecular analysis of regulatory mechanisms of human Fibroblast Growth Factor 1 gene expression. Presented at Dissertation. The Ohio State University. Columbus, OH.
  • Chotani, MA, Seminar Presenter. 2009. Vascular alpha 2C-adrenoceptors: from skin punch biopsy to the culture dish. 2nd International Workshop-cum-Training Course on Molecular Medicine and Drug Research. Karachi, Pakistan. (January)
  • Lucchesi, P, Presenter. 2002. Cardiac fibroblasts and heart failure. Experimental Biology. New Orleans, LA.
  • Hodgson, CP; Fisk, RZ; Hatzoglu, M; Arora, P; Chotani, MA; Hanson, RW, Poster Presenter. 1989. Mouse retovirus-like (VL-30) transposable element RNA is abundantly expressed in psi-2 helper cells, transferred to recipient rat hepatoma cells, and expressed in a dexamethasone-inducible fashion along with specifically vectored sequences: complete structure. Presented at Poster Session for 18th Annual UCLA Symposia on Biotechnology and Human Genetic Predisposition to Disease. Los Angeles, CA. (March)
  • Lucchesi, P, Presenter. 1984. Analysis of MNNG induced mutations in bacteria. Mutagenesis Society Meeting, University of Connecticut. Storrs, CT.
  • Chotani, MA; Mitra, S; Su, BY; Flavahan, S; Paris, H; Daunt, DA; Handy, DE; Clark, KR; Flavahan, NA, Presenter. 2000. Regulation of alpha2C-adrenergic receptor expression in vascular smooth muscle cells. Presented at ASMBM/ASPET 2000 Meeting. Boston, MA. (May)
  • Lucchesi, P, Presenter. 2003. Cytokines and vascular smooth muscle. AHA Scientific Session. Orlando, FL.
  • Lucchesi, P, Presenter. 2001. PYK2 and vascular smooth muscle growth: Choosy receptors pick PYK2. Gordon Research Conference "Angiotension". Ventura, CA.
  • Chotani, MA, Seminar Presenter. 1988. Use of ordered deletions in place of shotgun closing, and dideoxy sequencing of the mouse VL30 gene cloned in the pUC119 plasmid vector. Presented at Senior Independent Thesis presentation. The College of Wooster. Wooster, OH.
  • Zuo L, Youtz DJ, Wold LE. 2011. Diesel exhaust particle exposure exacerbates contractile dysfunction in diabetic-like cardiomyocytes. Cardiovascular Toxicology. [Peer Reviewed] (First submission)
  • Mihai, C; Chotani, MA; Iscru, DF; Garbellini, D; Elton, TS; Agarwal, G, Presenter. 2006. Investigating DDR1 oligomerization at the single molecule level. Presented at Fifth Annual Ohio State University Medical Center Graduate & Postgraduate Research Day. Columbus, OH. (March)
  • Stewart JA Jr; Hutchinson KR; Lord KC; Lucchesi PA, Poster Presenter. 2008. Role of Fibroblasts in Diabetic Cardiomyopathy. Presented at Experimental Biology. San Diego, CA.
  • Velten M, Hutchinson KR, Wold LE, Lucchesi PA, Rogers LK. 2011. Systemic maternal inflammation and neonatal hyperoxia induce cardiac remodeling and impair left ventricular function. European Heart Journal. [Peer Reviewed] (First submission)
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000